Insights
More Articles
- Moderna's COVID-19 vaccine wins approval in Switzerland
- EMA to launch accelerated review for AZ COVID-19 vaccine
- Bangledesh company reaches COVID-19 vaccine deal
- Priority review granted for 15-valent pneumococcal vaccine
- Eli Lilly's donanemab promising in Alzheimer's disease
Moderna's COVID-19 vaccine wins approval in Switzerland
Swissmedic, Switzerland's drug regulator, has approved Moderna's COVID-19 vaccine, the second vaccine authorized for emergency use after the Pfizer/BioNTech vaccine. The approval will allow for the delivery of up to 1.5 million doses from both companies through February. Reuters (1/12)
Read full article now.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!